Z79.02

Long term (current) use of antiplatelets

Long term (current) use of antiplatelets (Z79.02) is a clinical status code designated for patients who are currently receiving ongoing pharmacological therapy with antiplatelet agents. These medications, which include P2Y12 inhibitors like clopidogrel (Plavix), ticagrelor (Brilinta), and prasugrel (Effient), or glycoprotein IIb/IIIa inhibitors, function by preventing the aggregation of platelets, thereby inhibiting the formation of thrombi. This therapy is a cornerstone in the secondary prevention of cardiovascular and cerebrovascular events, particularly in patients with a history of myocardial infarction, ischemic stroke, or peripheral arterial disease. It is also essential for maintaining stent patency following percutaneous coronary intervention (PCI). It is important to note that ICD-10-CM specifies an 'Excludes1' note for long-term aspirin use, which should be coded as Z79.82 rather than Z79.02. Clinical management requires vigilant monitoring for signs of bleeding and ensuring patient adherence to prevent catastrophic thrombotic events.

Clinical Symptoms

  • Increased susceptibility to bruising (ecchymosis)
  • Prolonged bleeding from minor cuts or dental procedures
  • Frequent or severe nosebleeds (epistaxis)
  • Bleeding gums after brushing
  • Presence of petechiae (small red or purple skin spots)
  • Gastrointestinal bleeding indicators (melena or hematochezia)
  • Hematuria (blood in the urine)
  • Heavy menstrual bleeding (menorrhagia)
  • Occasional chest pain or shortness of breath (related to the underlying condition being treated)
  • Neurological deficits or TIA-like symptoms (indicators for current surveillance in stroke prevention patients)

Common Causes

  • History of myocardial infarction (secondary prevention)
  • Coronary artery disease (CAD)
  • Recent placement of coronary artery stents (drug-eluting or bare-metal)
  • History of ischemic stroke
  • History of transient ischemic attack (TIA)
  • Peripheral arterial disease (PAD)
  • Carotid artery stenosis
  • Following certain cardiac bypass surgeries (CABG)
  • Prophylaxis in high-risk patients with multiple atherosclerotic risk factors
  • Cerebrovascular disease requiring chronic antiplatelet therapy

Documentation & Coding Tips

Explicitly identify the specific antiplatelet agent used and the underlying condition requiring long-term therapy.

Example: The patient is an 68-year-old male with a history of atherosclerotic heart disease and a coronary artery stent placed in the left anterior descending artery 6 months ago. He is currently on long-term Clopidogrel 75mg daily for secondary prevention of myocardial infarction. He denies any abnormal bleeding, hematuria, or dark stools. His medication adherence is 100 percent.

Billing Focus: Documentation must specify the antiplatelet drug class and the chronicity of the use to support Z79.02 rather than an acute administration code.

Distinguish clearly between antiplatelets and anticoagulants to ensure correct code selection between Z79.02 and Z79.01.

Example: Patient with peripheral artery disease in the right lower extremity continues on long-term Ticagrelor 90mg BID. This is an antiplatelet therapy for vascular protection, distinct from anticoagulant needs for her history of paroxysmal atrial fibrillation managed elsewhere. No bruising or gingival bleeding noted on exam.

Billing Focus: Using the correct Z-code prevents claim denials related to medical necessity for lab monitoring, as anticoagulants require more frequent testing than antiplatelets.

When a patient is on dual antiplatelet therapy (DAPT) including aspirin, code both the antiplatelet use and the specific aspirin use.

Example: The patient is on a DAPT regimen following a recent stroke, consisting of long-term Aspirin 81mg and long-term Clopidogrel 75mg. Both medications are being used for secondary stroke prophylaxis. No history of GI ulceration or NSAID sensitivity.

Billing Focus: Report Z79.02 for the Clopidogrel and Z79.82 for the long-term use of aspirin to fully represent the therapeutic complexity.

Document the absence or presence of side effects such as bleeding or easy bruising to justify monitoring and management complexity.

Example: The patient is on long-term Prasugrel 10mg daily for coronary stent maintenance. Patient reports occasional ecchymosis on the forearms but denies epistaxis or melena. Hemoglobin is stable at 14.2 g/dL. Plan to continue current antiplatelet regimen with close monitoring.

Billing Focus: Including symptomatic review supports the level of medical decision making (MDM) for evaluation and management codes.

Link the medication use to the specific vascular anatomy or history of surgical intervention.

Example: Current status is post-carotid endarterectomy (left) for symptomatic carotid stenosis. Patient is maintained on long-term Dipyridamole for stroke prevention. The vascular surgical site is well-healed, and there are no neurological deficits.

Billing Focus: Providing the anatomical site and surgical history justifies the medical necessity for the specific medication and subsequent office visits.

Relevant CPT Codes

Related Diagnoses

Hierarchy